Dianthus Therapeutics (DNTH) Cash from Operations (QoQ) (2017 - 2025)
Dianthus Therapeutics (DNTH) Cash from Operations (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Dianthus Therapeutics | 3.92 Bn | 3.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -27.89% |
| Jun 30, 2025 | 13.53% |
| Mar 31, 2025 | -0.68% |
| Dec 31, 2024 | -29.04% |
| Sep 30, 2024 | -46.39% |
| Jun 30, 2024 | 2.76% |
| Mar 31, 2024 | -26.04% |
| Dec 31, 2023 | -18.63% |
| Sep 30, 2023 | -111.20% |
| Jun 30, 2023 | 54.00% |
| Mar 31, 2023 | -16.19% |
| Dec 31, 2022 | -154.05% |
| Sep 30, 2022 | 197.16% |
| Jun 30, 2022 | 14.63% |
| Mar 31, 2022 | -25.82% |
| Dec 31, 2021 | -11.54% |
| Sep 30, 2021 | -8.21% |
| Jun 30, 2021 | 22.50% |
| Mar 31, 2021 | -22.14% |
| Dec 31, 2020 | 4.82% |